Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CHIR

Chiron (CHIR)

Chiron (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CHIR
FechaHoraFuenteTítuloSímboloCompañía
28/04/200408:00PR Newswire (US)Chiron to Present at Morgan Stanley Global Healthcare Unplugged ConferenceNASDAQ:CHIRChiron (MM)
27/04/200411:19PR Newswire (US)Chiron to Present at Deutsche Bank Securities Health Care ConferenceNASDAQ:CHIRChiron (MM)
21/04/200416:00PR Newswire (US)Chiron Reports 2004 First-Quarter Pro-Forma Results of 22 Cents Per ShareNASDAQ:CHIRChiron (MM)
07/04/200408:30PR Newswire (US)Chiron to Release Earnings on Wednesday, April 21, 2004NASDAQ:CHIRChiron (MM)
19/03/200407:30PR Newswire (US)Chiron Announces Update on Tezacitabine ProgramNASDAQ:CHIRChiron (MM)
02/03/200407:05PR Newswire (US)Chiron to Discuss Plans for Phase III Clinical Development of TifacoginNASDAQ:CHIRChiron (MM)
02/03/200407:00PR Newswire (US)Chiron to Present at the SG Cowen 24th Annual Health Care ConferenceNASDAQ:CHIRChiron (MM)
01/03/200406:30PR Newswire (US)Chiron and XOMA Form Collaboration For Development and Commercialization Of Therapeutic Antibodies For CancerNASDAQ:CHIRChiron (MM)
25/02/200407:01PR Newswire (US)Chiron to Present at Lehman Brothers Seventh Annual Global Healthcare ConferenceNASDAQ:CHIRChiron (MM)
17/02/200407:00PR Newswire (US)Chiron Names Rino Rappuoli, Ph.D., Chief Scientific OfficerNASDAQ:CHIRChiron (MM)
12/02/200407:00PR Newswire (US)Chiron to Testify to Congress on Influenza VaccineNASDAQ:CHIRChiron (MM)
12/01/200407:02PR Newswire (US)Chiron Scales Up Production of New Meningococcal B Vaccine for New ZealandNASDAQ:CHIRChiron (MM)
12/01/200407:02PR Newswire (US)Chiron Delivers Additional Fluvirin(R) Flu Vaccine Doses to U.S. Department of Health and Human ServicesNASDAQ:CHIRChiron (MM)
09/01/200411:25PR Newswire (US)Chiron Announces Effectiveness of Registration Statement for Resale of 1 5/8% Convertible Debentures Due 2033NASDAQ:CHIRChiron (MM)
08/01/200407:30PR Newswire (US)Chiron Provides Update on Program Evaluating Use of Proleukin(R) Interleukin-2 with Monoclonal AntibodyNASDAQ:CHIRChiron (MM)
06/01/200407:30PR Newswire (US)Chiron to Present at JPMorgan 22nd Annual Healthcare ConferenceNASDAQ:CHIRChiron (MM)
05/01/200407:30PR Newswire (US)Chiron Licenses Technology from Infectio Diagnostic Inc. for Bacterial Detection System for PlateletsNASDAQ:CHIRChiron (MM)
05/01/200407:30PR Newswire (US)Chiron and ZymeQuest(R) form Partnership for Enzyme Conversion Of Red Blood CellsNASDAQ:CHIRChiron (MM)
18/12/200307:00PR Newswire (US)Chiron Grants Nonexclusive HCV License to Boehringer IngelheimNASDAQ:CHIRChiron (MM)
11/12/200307:00PR Newswire (US)Clinical Trials Begin for Procleix(R) Ultrio(TM) AssayNASDAQ:CHIRChiron (MM)
10/12/200302:00PR Newswire (US)/C O R R E C T I O N -- Chiron Corporation/NASDAQ:CHIRChiron (MM)
10/12/200302:00PR Newswire (US)Rocleix Testing Begins In EnglandNASDAQ:CHIRChiron (MM)
10/12/200301:00PR Newswire (US)Procleix(R) Testing Begins in EnglandNASDAQ:CHIRChiron (MM)
09/12/200315:04PR Newswire (US)Chiron Increased Fluvirin(R) Influenza Vaccine Production for U.S. Market by Approximately 50 Percent Over 2002-2003 Flu SeasonNASDAQ:CHIRChiron (MM)
04/12/200307:00PR Newswire (US)Chiron to Present at the Harris Nesbitt Gerard Focus on Healthcare Conference 2003NASDAQ:CHIRChiron (MM)
24/11/200307:30PR Newswire (US)Chiron Announces Launch of ELITE TrialNASDAQ:CHIRChiron (MM)
12/11/200315:00PR Newswire (US)Gen-Probe and Chiron Amend Blood Screening Collaboration Agreement to Set Fixed Revenue SharesNASDAQ:CHIRChiron (MM)
07/11/200318:15PR Newswire (US)Chiron Grants Nonexclusive HCV License to VertexNASDAQ:CHIRChiron (MM)
06/11/200315:07PR Newswire (US)Chiron Names David Smith CFONASDAQ:CHIRChiron (MM)
06/11/200307:00PR Newswire (US)Chiron Opens State-of-the-Art Blood Screening Lab in ChinaNASDAQ:CHIRChiron (MM)
 Showing the most relevant articles for your search:NASDAQ:CHIR